» Articles » PMID: 36812393

Methods for Informing People with Amyotrophic Lateral Sclerosis/motor Neuron Disease of Their Diagnosis

Overview
Publisher Wiley
Date 2023 Feb 22
PMID 36812393
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), causes increasing physical impairment and disability. People with ALS/MND face huge physical challenges, and the diagnosis can be a source of great psychological distress for both people with ALS/MND and their carers. In such a context, how news of the diagnosis is broken is important. At present, there are no systematic reviews of methods for informing people with ALS/MND of their diagnosis.

Objectives: To examine the effects and effectiveness of different methods for informing people of a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND), including effects on the person's knowledge and understanding of their disease, its treatment, and care; and on coping and adjustment to the effects of ALS/MND, its treatment, and care.

Search Methods: We searched the Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, and two trials registers (February 2022). We contacted individuals or organisations to locate studies. We contacted study authors to obtain additional unpublished data.

Selection Criteria: We planned to include randomised controlled trials (RCTs) and quasi-RCTs of techniques for informing people with ALS/MND of their diagnosis. We planned to include adults (aged 17 years or over) with ALS/MND, according to the El Escorial criteria.

Data Collection And Analysis: Three review authors independently reviewed the results of the search to identify RCTs, and three review authors identified non-randomised studies to include in the discussion section. We planned that two review authors would independently extract data, and three would assess the risk of bias in any included trials.

Main Results: We did not identify any RCTs that met our inclusion criteria.

Authors' Conclusions: There are no RCTs that evaluate different communication strategies for breaking the bad news for people diagnosed with ALS/MND. Focused research studies are needed to assess the effectiveness and efficacy of different communication methods.

Citing Articles

"…but I know something's not right here": Exploring the diagnosis and disclosure experiences of persons living with ALS.

Foldvari K, Stolee P, Neiterman E, Boscart V, Tong C PLoS One. 2024; 19(12):e0301249.

PMID: 39621705 PMC: 11611097. DOI: 10.1371/journal.pone.0301249.


Methods for informing people with amyotrophic lateral sclerosis/motor neuron disease of their diagnosis.

Bongioanni P, Borasio G, Oliver D, Romagnoli A, Kapitza K, Sidle K Cochrane Database Syst Rev. 2023; 2:CD007593.

PMID: 36812393 PMC: 9944678. DOI: 10.1002/14651858.CD007593.pub2.


Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.

Ng L, Khan F, Young C, Galea M Cochrane Database Syst Rev. 2017; 1:CD011776.

PMID: 28072907 PMC: 6469543. DOI: 10.1002/14651858.CD011776.pub2.

References
1.
Rudnick A, Ezra Y, Melamed E . Breaking bad news and personality assessment. Patient Educ Couns. 2002; 41(2):157-60. DOI: 10.1016/s0738-3991(99)00106-8. View

2.
Seeber A, Pols A, Hijdra A, Grupstra H, Willems D, de Visser M . Experiences and reflections of patients with motor neuron disease on breaking the news in a two-tiered appointment: a qualitative study. BMJ Support Palliat Care. 2016; 9(1):e8. DOI: 10.1136/bmjspcare-2015-000977. View

3.
Meininger V . Breaking bad news in amyotrophic lateral sclerosis. Palliat Med. 1993; 7(4 Suppl):37-40. DOI: 10.1177/0269216393007004S07. View

4.
. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 17(12):1083-1097. PMC: 6234315. DOI: 10.1016/S1474-4422(18)30404-6. View

5.
Corcia P . [Methods of the announcement of amyotrophic lateral sclerosis diagnosis in familial forms]. Rev Neurol (Paris). 2006; 162 Spec No 2:4S122-4S126. View